SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Johnson & Johnson Prostate Cancer Drug Shrinks Tumors in Early-Stage Study

Johnson & Johnson's prostate cancer drug shrank tumors in an early-stage study.

JNJ

Related stories